Regarding BRCA1 expression, Chen et al. found that patients with GC and negative BRCA1 expression saw a greater OS benefit compared to patients with positive BRCA1 expression when administered platinum-based adjuvant chemotherapy [32]. Here, BRCA1 is linked to gastric cancer.